PAVANJIT BRAR: Open Payments
NPI 1033250774 · TORRANCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$511 in 26 payments from 9 companies in 2025. Trend: 2023 $683 · 2024 $643 · 2025 $511
Food & beverage: $511
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $145 |
| Novo Nordisk Inc | 5 | $86 |
| PFIZER INC. | 3 | $77 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Amgen Inc. | 2 | $41 |
| Intra-Sana Laboratories | 2 | $33 |
| Phadia US Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
Products named: AIRSUPRA, PREVNAR 20, Auvelity, Rybelsus, OTEZLA, RELTONE 200 MG, FARXIGA, ImmunoCAP.
Industry payments across CA — which companies pay providers there.
